Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study.
MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
Extracellular Cues Influencing Oligodendrocyte Differentiation and (Re)myelination.
Clinically isolated syndrome - Rethinking the diagnosis.
De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Experimental models of spontaneous autoimmune disease in the central nervous system.
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
The neuroendocrine axis in patients with multiple sclerosis.
Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
TECFIDERA prescribing information
Oral BG-12 (dimethyl fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression in DEFINE Phase 3 clinical trial
Pregnancy and multiple sclerosis.
A New Colour Reaction on Copper and Certain Carbonyl Compounds
Effects of dimethyl fumarate on neuroprotection and immunomodulation.

Pages